GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ANG-PD · Mar 31, 2018

American National Group Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001039828-18-000027Insurance
Cash30thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$723.8M · CORE · VALID

Policy-benefit growth35thOwn-history percentile · N=17
Evidence method

Yoy · gp.insurance.policy_benefits

1.84% · OPTIONAL · VALID

Net-income growth93thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.net_income

161.34% · CORE · VALID

Premium growth29thOwn-history percentile · N=17
Evidence method

Yoy · gp.insurance.premiums

-3.71% · CORE · VALID

Revenue growth0thOwn-history percentile · N=17
Evidence method

Yoy · gp.fundamentals.revenue

-87.18% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Cash Decreased
Previous
$1.4B
Current
$723.8M
Delta
-$710.3M
Claims Growth Increased
Previous
-17.65%
Current
1.84%
Delta
19.50%
Earnings Growth Increased
Previous
109.80%
Current
161.34%
Delta
51.53%
Premium Growth Increased
Previous
-21.80%
Current
-3.71%
Delta
18.08%
Revenue Growth Decreased
Previous
75.28%
Current
-87.18%
Delta
-162.46%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.